Vascepa (icosapent ethyl) is a prescription medication used to treat high levels of triglycerides in the blood. Statins, on the other hand, are medications that help lower cholesterol levels. When combined, they can provide additional benefits for patients with cardiovascular disease.

According to a study published in the American Journal of Managed Care [2], patients taking Vascepa in combination with statins experienced a significant reduction in cardiovascular events such as heart attacks, strokes, and death from cardiovascular causes. The study found that the benefits of Vascepa were consistent across different types of statins, indicating that the combination can be effective regardless of the specific type of statin being taken.

Another benefit of combining Vascepa with statins is that it can help patients achieve their cholesterol and triglyceride goals more effectively than either medication alone. Vascepa has been shown to reduce triglyceride levels by up to 33% [3], while statins can lower LDL cholesterol levels by up to 55% [2]. Combining the two medications can result in a more comprehensive approach to managing cardiovascular risk factors.

It is important to note that combining medications can also increase the risk of side effects and drug interactions. Patients should always consult with their healthcare provider before starting or changing any medications.

In conclusion, combining Vascepa with statins can provide additional benefits for patients with high triglyceride levels and cardiovascular disease. It can help reduce the risk of cardiovascular events and help patients achieve their cholesterol and triglyceride goals more effectively. However, patients should always consult with their healthcare provider before starting or changing any medications.

Sources:
[2] https://www.ajmc.com/view/patients-take-different-statins-but-vascepa-benefits-are-the-same
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa